Use of major histocompatibility complex (mhc) - xeno antibody genes in the manufacture of a medicament for a therapeutic treatment of cancer

摘要

Allo-, iso- and xenoantigens, chosen from histocompatibility molecules obtained by extraction from homogenates of tissues or cells with Nonidet P40 or 1 N HClO4, are disclosed for use as a medicament for stimulation of the immune system of man and mammals, and in particular for cancer therapy.